Causal effect of anxiety and depression status on the symptoms of gastroesophageal reflux disease and functional dyspepsia during proton pump inhibitor therapy

[1]  Tasia Esterita,et al.  Association of Functional Dyspepsia with Depression and Anxiety: A Systematic Review. , 2021, Journal of gastrointestinal and liver diseases : JGLD.

[2]  K. Haruma,et al.  Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study , 2019, Journal of Gastroenterology.

[3]  J. Choi,et al.  Association Between Anxiety and Depression and Gastroesophageal Reflux Disease: Results From a Large Cross-sectional Study , 2018, Journal of neurogastroenterology and motility.

[4]  K. Haruma,et al.  Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms , 2017, World journal of gastroenterology.

[5]  T. Tomita,et al.  A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia , 2017, Journal of Gastroenterology.

[6]  R. Cuomo,et al.  Specific dyspeptic symptoms are associated with poor response to therapy in patients with gastroesophageal reflux disease , 2017, United European gastroenterology journal.

[7]  Y. Fujiwara,et al.  Associations among gastroesophageal reflux disease, psychological stress, and sleep disturbances in Japanese adults , 2017, Scandinavian journal of gastroenterology.

[8]  H. Roohafza,et al.  Association of anxiety, depression, and psychological distress in people with and without functional dyspepsia , 2016, Advanced biomedical research.

[9]  Jun Song,et al.  Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. , 2015, World journal of gastroenterology.

[10]  K. Haruma,et al.  Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study , 2015, Journal of Gastroenterology.

[11]  Lin Jia,et al.  Incidence and psychological-behavioral characteristics of refractory functional dyspepsia: a large, multi-center, prospective investigation from China. , 2015, World journal of gastroenterology.

[12]  Y. Fujiwara,et al.  Overlap in Patients With Dyspepsia/Functional Dyspepsia , 2014, Journal of neurogastroenterology and motility.

[13]  Baoping Yu,et al.  Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease. , 2013, World journal of gastroenterology.

[14]  S. B. des Varannes,et al.  Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease , 2011, Gut.

[15]  H. Mönnikes,et al.  Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole , 2011, BMC gastroenterology.

[16]  Myung-Gyu Choi,et al.  Relationship between Psychological Factors and Quality of Life in Subtypes of Gastroesophageal Reflux Disease , 2009, Gut and liver.

[17]  Ri-Nan Zheng.  Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis. , 2009, World journal of gastroenterology.

[18]  G. Gerken,et al.  Impairment of health‐related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety , 2008, Alimentary pharmacology & therapeutics.

[19]  N. Talley,et al.  Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? , 2007, Alimentary pharmacology & therapeutics.

[20]  M. Samsom,et al.  Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease , 2007, Scandinavian journal of gastroenterology.

[21]  J. Dent,et al.  The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus , 2006, The American Journal of Gastroenterology.

[22]  M. Hongo.  Minimal changes in reflux esophagitis: red ones and white ones , 2006, Journal of Gastroenterology.

[23]  M. Ravic,et al.  Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment , 2006, Scandinavian journal of gastroenterology.

[24]  T. Ohkusa,et al.  Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review , 2005, Journal of Gastroenterology.

[25]  J. Ware,et al.  Usefulness of the SF-8™ Health Survey for comparing the impact of migraine and other conditions , 2003, Quality of Life Research.

[26]  Jacob Cohen,et al.  A power primer. , 1992, Psychological bulletin.

[27]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[28]  D. A. Kenny,et al.  Cross-lagged panel correlation: A test for spuriousness. , 1975 .

[29]  H. Imamura,et al.  Changes of upper gastrointestinal symptoms and endoscopic findings in Japan over 25 years. , 2011, Internal medicine.

[30]  T. Abell,et al.  Effect of cisapride therapy for severe dyspepsia on gastrointestinal symptoms and quality of life. , 1993, Scandinavian journal of gastroenterology. Supplement.